UNITED THERAPEUTICS Corp: ROTHBLATT MARTINE A amends Schedule 13G stake filing
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
Martine A. Rothblatt amended her Schedule 13G stake filing for United Therapeutics Corp, per SEC accession 0001104659-26-122747. The filing updates her previously reported beneficial ownership position in the company. The exact size and direction of the stake change were not disclosed in the headline. The amendment matters because Rothblatt is a closely watched insider at the pulmonary hypertension drugmaker. Investors will watch for the full filing details to gauge whether her position increased or decreased.
Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.
Named in this story
United Therapeutics Corp, Martine A Rothblatt